Lupin receives USFDA approval for generic Brivaracetam Oral Solution to treat seizures, initiating its U.S. market launch.

ClearML integrates its AI Infrastructure Platform with the VAST AI Operating System to accelerate enterprise AI ...

Lupin has received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) for Brivaracetam Oral Solution 10 mg/mL. Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 ...

ML is poised to become faster and more accessible by 2026. Simply having the support of GenAI already gives it an advantage over other AI-based solutions.

The pharma giant has officially secured USFDA approval for its generic version of the seizure medication Brivaracetam.

Drugmaker Lupin on Wednesday said it has initiated launch of Brivaracetam Oral Solution 10 mg/mL in the United States following U.S. Food and Drug Administration (U.S. FDA) approval for its ...

Lupin receives USFDA approval for generic Brivaracetam Oral Solution to treat partial-onset seizures. Launch initiated in the US market.

FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.

With a heritage in hyperconverged infrastructure, the Nutanix of 2026 is one firmly focused on explaining how its approach to ...

The job market evolves with different needs everyday, with jobseekers positioning themselves with relevant skills and ...

Datavault AI (NASDAQ: DVLT) highlighted the strategic importance of its New York and Philadelphia edge network ...

Plasma brain-derived Tau is quantified using a novel luminescence immunoassay, demonstrating improved sensitivity for ...